Researchers at Cedars-Sinai and NeuroVision publish proof-of-concept study on experimental optical imaging system, demonstrating detection of retinal beta-amyloid, a hallmark of Alzheimer’s disease
The associate director in the Product Management group at Taconic Biosciences takes a
look at where CRISPR has been, where it is now, where it is going and what that could all mean for getting the most out of this popular gene-editing
technology